A complaint filed with the U.S. Department of Justice (DOJ) alleges that Alabama’s Medicaid program is illegally denying curative drug treatment for hepatitis C virus (HCV) infection to people with substance use disorder.
Trending
- Physician hiring, turnover increases after practices acquired by private equity, study finds (Fierce Healthcare)
- Supreme Court Case Could Threaten Free Colorectal Cancer Screenings (AJMC)
- Hospitals line up to sue Blue Cross, opting out of $2.8 bln settlement (Reuters)
- ChatGPT Competes With Surgeons in Patient Q&A (Medscape)
- Richard Peek to serve as president of international gastroenterology group (VUMC)
- Medicare To Reimburse Guardant Health’s Shield Colorectal Cancer Test, Analyst Expects $10M In Revenue (Benzinga)
- Why the Hinge Health IPO is so important for digital health (Second Opinion)
- Nine guideline-based best practices for IBS (AGA)
